Company / Profit Margin
Acadia Pharmaceuticals Profit Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
36.5%
FY2025
5-year range
-41.8% / 36.5%
FY2021-FY2025
Trend
+54.4%
vs FY2024
Sector context
#12 of 145
Health Care
What the data says
Among 145 Health Care companies, Acadia Pharmaceuticals is in the top 8% for profit margin. Profit Margin has increased for 3 consecutive years, from -41.8% in FY2022 to 36.5% in FY2025.
Based on SEC 10-K filings.
36.5% in FY2025 with a 5-year CAGR of +100.2%. Top quartile in the Health Care sector.
Improved from -8.4% to 36.5% over the past 2 years.
Health Care sector context is included.
Profit Margin over time
Growth rates
- 3-Year Change
- +78.3pp
- 5-Year Change
- +100.2pp
- 10-Year Change
- -
Sector benchmark
Top 8% in Health CareTop 8% of 145This company 36.5% Sector average -792.7%
▼
+104.6% above sector average
Key checks
Key Insights
- Acadia Pharmaceuticals's profit margin has grown for 3 consecutive years.
- In FY2025, profit margin increased 54.4% year-over-year.
- Currently 829.2pp above the Health Care sector average.
- Lowest profit margin in the period was in FY2016.
Company context
Key Data Points
- Strong profit margin: 24.9%
- Low earnings quality (accrual-heavy earnings)
- Strong return on equity: 28.5%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 36.5% | +54.4% |
| FY2024 | 23.6% | +380.1% |
| FY2023 | -8.4% | +79.8% |
| FY2022 | -41.8% | -20.4% |
| FY2021 | -34.7% | +45.6% |
| FY2020 | -63.7% | +8.1% |
| FY2019 | -69.4% | +36.7% |
| FY2018 | -109.6% | +52.7% |
| FY2017 | -231.7% | +85.2% |
| FY2016 | -1565.9% | +99.4% |
As of FY2025 · SEC 10-K · Updated Jul 1, 2026